Global Metastatic Melanoma Drug Sales Market Report 2018

June 2018 | 116 pages | ID: GCA18B8050AEN
QYResearch

Abstracts

This report studies the global Metastatic Melanoma Drug market status and forecast, categorizes the global Metastatic Melanoma Drug market size (value & volume) by key players, type, application, and region.
This report focuses on the top players in North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America).

The global Metastatic Melanoma Drug market is valued at million US$ in 2017 and will reach million US$ by the end of 2025, growing at a CAGR of during 2018-2025.
The major players covered in this report

• Merck & Co., Inc.
• Merck KGaA
• Millennium Pharmaceuticals, Inc.
• Morphotek, Inc.
• NewLink Genetics Corporation
• Novartis AG
• Omeros Corporation
• Oncolytics Biotech Inc.
• OncoSec Medical Inc.
• Ono Pharmaceutical Co., Ltd.
• Pfizer Inc.
• Pharmis Biofarmaceutica, Lda.
• Philogen S.p.A.
• Plexxikon Inc.

Geographically, this report studies the key regions, focuses on product sales, value, market share and growth opportunity in these regions, covering

• United States
• Europe
• China
• Japan
• Southeast Asia
• India

We can also provide the customized separate regional or country-level reports, for the following regions:

• North America
• United States
• Canada
• Mexico
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Australia
• Indonesia
• Singapore
• Rest of Asia-Pacific
• Europe
• Germany
• France
• UK
• Italy
• Spain
• Russia
• Rest of Europe
• Central & South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Saudi Arabia
• Turkey
• Rest of Middle East & Africa

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• AGI-134
• ALT-801
• ALT-803
• AMG-232
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Clinic
• Others

The study objectives of this report are:

• To analyze and study the global Metastatic Melanoma Drug sales, value, status (2013-2017) and forecast (2018-2025);
• To analyze the top players in North America, Europe, China, Japan, Southeast Asia and India, to study the sales, value and market share of top players in these regions.
• Focuses on the key Metastatic Melanoma Drug players, to study the sales, value, market share and development plans in future.
• Focuses on the global key manufacturers, to define, describe and analyze the market competition landscape, SWOT analysis.
• To define, describe and forecast the market by type, application and region.
• To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
• To identify significant trends and factors driving or inhibiting the market growth.
• To analyze the opportunities in the market for stakeholders by identifying the high growth segments.
• To strategically analyze each submarket with respect to individual growth trend and their contribution to the market
• To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market
• To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Metastatic Melanoma Drug are as follows:

• History Year: 2013-2017
• Base Year: 2017
• Estimated Year: 2018
• Forecast Year 2018 to 2025

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Key Stakeholders

Metastatic Melanoma Drug Manufacturers
Metastatic Melanoma Drug Distributors/Traders/Wholesalers
Metastatic Melanoma Drug Subcomponent Manufacturers
Industry Association
Downstream Vendors
Available Customizations

With the given market data, QYResearch offers customizations according to the company's specific needs. The following customization options are available for the report:

• Regional and country-level analysis of the Metastatic Melanoma Drug market, by end-use.
• Detailed analysis and profiles of additional market players.

Contents

Global Metastatic Melanoma Drug Sales Market Report 2018

1 METASTATIC MELANOMA DRUG MARKET OVERVIEW

1.1 Product Overview and Scope of Metastatic Melanoma Drug
1.2 Classification of Metastatic Melanoma Drug by Product Category
  1.2.1 Global Metastatic Melanoma Drug Market Size (Sales) Comparison by Type (2013-2025)
  1.2.2 Global Metastatic Melanoma Drug Market Size (Sales) Market Share by Type (Product Category) in 2017
  1.2.3 AGI-134
  1.2.4 ALT-801
  1.2.5 ALT-803
  1.2.6 AMG-232
  1.2.7 Others
1.3 Global Metastatic Melanoma Drug Market by Application/End Users
  1.3.1 Global Metastatic Melanoma Drug Sales (Volume) and Market Share Comparison by Application (2013-2025)
  1.3.1 Hospital
  1.3.2 Clinic
  1.3.3 Others
1.4 Global Metastatic Melanoma Drug Market by Region
  1.4.1 Global Metastatic Melanoma Drug Market Size (Value) Comparison by Region (2013-2025)
  1.4.2 United States Metastatic Melanoma Drug Status and Prospect (2013-2025)
  1.4.3 Europe Metastatic Melanoma Drug Status and Prospect (2013-2025)
  1.4.4 China Metastatic Melanoma Drug Status and Prospect (2013-2025)
  1.4.5 Japan Metastatic Melanoma Drug Status and Prospect (2013-2025)
  1.4.6 Southeast Asia Metastatic Melanoma Drug Status and Prospect (2013-2025)
  1.4.7 India Metastatic Melanoma Drug Status and Prospect (2013-2025)
1.5 Global Market Size (Value and Volume) of Metastatic Melanoma Drug (2013-2025)
  1.5.1 Global Metastatic Melanoma Drug Sales and Growth Rate (2013-2025)
  1.5.2 Global Metastatic Melanoma Drug Revenue and Growth Rate (2013-2025)

2 GLOBAL METASTATIC MELANOMA DRUG COMPETITION BY PLAYERS/SUPPLIERS, TYPE AND APPLICATION

2.1 Global Metastatic Melanoma Drug Market Competition by Players/Suppliers
  2.1.1 Global Metastatic Melanoma Drug Sales and Market Share of Key Players/Suppliers (2013-2018)
  2.1.2 Global Metastatic Melanoma Drug Revenue and Share by Players/Suppliers (2013-2018)
2.2 Global Metastatic Melanoma Drug (Volume and Value) by Type
  2.2.1 Global Metastatic Melanoma Drug Sales and Market Share by Type (2013-2018)
  2.2.2 Global Metastatic Melanoma Drug Revenue and Market Share by Type (2013-2018)
2.3 Global Metastatic Melanoma Drug (Volume and Value) by Region
  2.3.1 Global Metastatic Melanoma Drug Sales and Market Share by Region (2013-2018)
  2.3.2 Global Metastatic Melanoma Drug Revenue and Market Share by Region (2013-2018)
2.4 Global Metastatic Melanoma Drug (Volume) by Application

3 UNITED STATES METASTATIC MELANOMA DRUG (VOLUME, VALUE AND SALES PRICE)

3.1 United States Metastatic Melanoma Drug Sales and Value (2013-2018)
  3.1.1 United States Metastatic Melanoma Drug Sales and Growth Rate (2013-2018)
  3.1.2 United States Metastatic Melanoma Drug Revenue and Growth Rate (2013-2018)
  3.1.3 United States Metastatic Melanoma Drug Sales Price Trend (2013-2018)
3.2 United States Metastatic Melanoma Drug Sales Volume and Market Share by Players (2013-2018)
3.3 United States Metastatic Melanoma Drug Sales Volume and Market Share by Type (2013-2018)
3.4 United States Metastatic Melanoma Drug Sales Volume and Market Share by Application (2013-2018)

4 EUROPE METASTATIC MELANOMA DRUG (VOLUME, VALUE AND SALES PRICE)

4.1 Europe Metastatic Melanoma Drug Sales and Value (2013-2018)
  4.1.1 Europe Metastatic Melanoma Drug Sales and Growth Rate (2013-2018)
  4.1.2 Europe Metastatic Melanoma Drug Revenue and Growth Rate (2013-2018)
  4.1.3 Europe Metastatic Melanoma Drug Sales Price Trend (2013-2018)
4.2 Europe Metastatic Melanoma Drug Sales Volume and Market Share by Players (2013-2018)
4.3 Europe Metastatic Melanoma Drug Sales Volume and Market Share by Type (2013-2018)
4.4 Europe Metastatic Melanoma Drug Sales Volume and Market Share by Application (2013-2018)

5 CHINA METASTATIC MELANOMA DRUG (VOLUME, VALUE AND SALES PRICE)

5.1 China Metastatic Melanoma Drug Sales and Value (2013-2018)
  5.1.1 China Metastatic Melanoma Drug Sales and Growth Rate (2013-2018)
  5.1.2 China Metastatic Melanoma Drug Revenue and Growth Rate (2013-2018)
  5.1.3 China Metastatic Melanoma Drug Sales Price Trend (2013-2018)
5.2 China Metastatic Melanoma Drug Sales Volume and Market Share by Players (2013-2018)
5.3 China Metastatic Melanoma Drug Sales Volume and Market Share by Type (2013-2018)
5.4 China Metastatic Melanoma Drug Sales Volume and Market Share by Application (2013-2018)

6 JAPAN METASTATIC MELANOMA DRUG (VOLUME, VALUE AND SALES PRICE)

6.1 Japan Metastatic Melanoma Drug Sales and Value (2013-2018)
  6.1.1 Japan Metastatic Melanoma Drug Sales and Growth Rate (2013-2018)
  6.1.2 Japan Metastatic Melanoma Drug Revenue and Growth Rate (2013-2018)
  6.1.3 Japan Metastatic Melanoma Drug Sales Price Trend (2013-2018)
6.2 Japan Metastatic Melanoma Drug Sales Volume and Market Share by Players (2013-2018)
6.3 Japan Metastatic Melanoma Drug Sales Volume and Market Share by Type (2013-2018)
6.4 Japan Metastatic Melanoma Drug Sales Volume and Market Share by Application (2013-2018)

7 SOUTHEAST ASIA METASTATIC MELANOMA DRUG (VOLUME, VALUE AND SALES PRICE)

7.1 Southeast Asia Metastatic Melanoma Drug Sales and Value (2013-2018)
  7.1.1 Southeast Asia Metastatic Melanoma Drug Sales and Growth Rate (2013-2018)
  7.1.2 Southeast Asia Metastatic Melanoma Drug Revenue and Growth Rate (2013-2018)
  7.1.3 Southeast Asia Metastatic Melanoma Drug Sales Price Trend (2013-2018)
7.2 Southeast Asia Metastatic Melanoma Drug Sales Volume and Market Share by Players (2013-2018)
7.3 Southeast Asia Metastatic Melanoma Drug Sales Volume and Market Share by Type (2013-2018)
7.4 Southeast Asia Metastatic Melanoma Drug Sales Volume and Market Share by Application (2013-2018)

8 INDIA METASTATIC MELANOMA DRUG (VOLUME, VALUE AND SALES PRICE)

8.1 India Metastatic Melanoma Drug Sales and Value (2013-2018)
  8.1.1 India Metastatic Melanoma Drug Sales and Growth Rate (2013-2018)
  8.1.2 India Metastatic Melanoma Drug Revenue and Growth Rate (2013-2018)
  8.1.3 India Metastatic Melanoma Drug Sales Price Trend (2013-2018)
8.2 India Metastatic Melanoma Drug Sales Volume and Market Share by Players (2013-2018)
8.3 India Metastatic Melanoma Drug Sales Volume and Market Share by Type (2013-2018)
8.4 India Metastatic Melanoma Drug Sales Volume and Market Share by Application (2013-2018)

9 GLOBAL METASTATIC MELANOMA DRUG PLAYERS/SUPPLIERS PROFILES AND SALES DATA

9.1 Merck & Co., Inc.
  9.1.1 Company Basic Information, Manufacturing Base and Competitors
  9.1.2 Metastatic Melanoma Drug Product Category, Application and Specification
    9.1.2.1 Product A
    9.1.2.2 Product B
  9.1.3 Merck & Co., Inc. Metastatic Melanoma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.1.4 Main Business/Business Overview
9.2 Merck KGaA
  9.2.1 Company Basic Information, Manufacturing Base and Competitors
  9.2.2 Metastatic Melanoma Drug Product Category, Application and Specification
    9.2.2.1 Product A
    9.2.2.2 Product B
  9.2.3 Merck KGaA Metastatic Melanoma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.2.4 Main Business/Business Overview
9.3 Millennium Pharmaceuticals, Inc.
  9.3.1 Company Basic Information, Manufacturing Base and Competitors
  9.3.2 Metastatic Melanoma Drug Product Category, Application and Specification
    9.3.2.1 Product A
    9.3.2.2 Product B
  9.3.3 Millennium Pharmaceuticals, Inc. Metastatic Melanoma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.3.4 Main Business/Business Overview
9.4 Morphotek, Inc.
  9.4.1 Company Basic Information, Manufacturing Base and Competitors
  9.4.2 Metastatic Melanoma Drug Product Category, Application and Specification
    9.4.2.1 Product A
    9.4.2.2 Product B
  9.4.3 Morphotek, Inc. Metastatic Melanoma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.4.4 Main Business/Business Overview
9.5 NewLink Genetics Corporation
  9.5.1 Company Basic Information, Manufacturing Base and Competitors
  9.5.2 Metastatic Melanoma Drug Product Category, Application and Specification
    9.5.2.1 Product A
    9.5.2.2 Product B
  9.5.3 NewLink Genetics Corporation Metastatic Melanoma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.5.4 Main Business/Business Overview
9.6 Novartis AG
  9.6.1 Company Basic Information, Manufacturing Base and Competitors
  9.6.2 Metastatic Melanoma Drug Product Category, Application and Specification
    9.6.2.1 Product A
    9.6.2.2 Product B
  9.6.3 Novartis AG Metastatic Melanoma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.6.4 Main Business/Business Overview
9.7 Omeros Corporation
  9.7.1 Company Basic Information, Manufacturing Base and Competitors
  9.7.2 Metastatic Melanoma Drug Product Category, Application and Specification
    9.7.2.1 Product A
    9.7.2.2 Product B
  9.7.3 Omeros Corporation Metastatic Melanoma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.7.4 Main Business/Business Overview
9.8 Oncolytics Biotech Inc.
  9.8.1 Company Basic Information, Manufacturing Base and Competitors
  9.8.2 Metastatic Melanoma Drug Product Category, Application and Specification
    9.8.2.1 Product A
    9.8.2.2 Product B
  9.8.3 Oncolytics Biotech Inc. Metastatic Melanoma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.8.4 Main Business/Business Overview
9.9 OncoSec Medical Inc.
  9.9.1 Company Basic Information, Manufacturing Base and Competitors
  9.9.2 Metastatic Melanoma Drug Product Category, Application and Specification
    9.9.2.1 Product A
    9.9.2.2 Product B
  9.9.3 OncoSec Medical Inc. Metastatic Melanoma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.9.4 Main Business/Business Overview
9.10 Ono Pharmaceutical Co., Ltd.
  9.10.1 Company Basic Information, Manufacturing Base and Competitors
  9.10.2 Metastatic Melanoma Drug Product Category, Application and Specification
    9.10.2.1 Product A
    9.10.2.2 Product B
  9.10.3 Ono Pharmaceutical Co., Ltd. Metastatic Melanoma Drug Sales, Revenue, Price and Gross Margin (2013-2018)
  9.10.4 Main Business/Business Overview
9.11 Pfizer Inc.
9.12 Pharmis Biofarmaceutica, Lda.
9.13 Philogen S.p.A.
9.14 Plexxikon Inc.

10 METASTATIC MELANOMA DRUG MAUFACTURING COST ANALYSIS

10.1 Metastatic Melanoma Drug Key Raw Materials Analysis
  10.1.1 Key Raw Materials
  10.1.2 Price Trend of Key Raw Materials
  10.1.3 Key Suppliers of Raw Materials
  10.1.4 Market Concentration Rate of Raw Materials
10.2 Proportion of Manufacturing Cost Structure
  10.2.1 Raw Materials
  10.2.2 Labor Cost
  10.2.3 Manufacturing Process Analysis of Metastatic Melanoma Drug
10.3 Manufacturing Process Analysis of Metastatic Melanoma Drug

11 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

11.1 Metastatic Melanoma Drug Industrial Chain Analysis
11.2 Upstream Raw Materials Sourcing
11.3 Raw Materials Sources of Metastatic Melanoma Drug Major Manufacturers in 2017
11.4 Downstream Buyers

12 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

12.1 Marketing Channel
  12.1.1 Direct Marketing
  12.1.2 Indirect Marketing
  12.1.3 Marketing Channel Development Trend
12.2 Market Positioning
  12.2.1 Pricing Strategy
  12.2.2 Brand Strategy
  12.2.3 Target Client
12.3 Distributors/Traders List

13 MARKET EFFECT FACTORS ANALYSIS

13.1 Technology Progress/Risk
  13.1.1 Substitutes Threat
  13.1.2 Technology Progress in Related Industry
13.2 Consumer Needs/Customer Preference Change
13.3 Economic/Political Environmental Change

14 GLOBAL METASTATIC MELANOMA DRUG MARKET FORECAST (2018-2025)

14.1 Global Metastatic Melanoma Drug Sales Volume, Revenue and Price Forecast (2018-2025)
  14.1.1 Global Metastatic Melanoma Drug Sales Volume and Growth Rate Forecast (2018-2025)
  14.1.2 Global Metastatic Melanoma Drug Revenue and Growth Rate Forecast (2018-2025)
  14.1.3 Global Metastatic Melanoma Drug Price and Trend Forecast (2018-2025)
14.2 Global Metastatic Melanoma Drug Sales Volume, Revenue and Growth Rate Forecast by Region (2018-2025)
  14.2.1 Global Metastatic Melanoma Drug Sales Volume and Growth Rate Forecast by Regions (2018-2025)
  14.2.2 Global Metastatic Melanoma Drug Revenue and Growth Rate Forecast by Regions (2018-2025)
  14.2.3 United States Metastatic Melanoma Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.4 Europe Metastatic Melanoma Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.5 China Metastatic Melanoma Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.6 Japan Metastatic Melanoma Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.7 Southeast Asia Metastatic Melanoma Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
  14.2.8 India Metastatic Melanoma Drug Sales Volume, Revenue and Growth Rate Forecast (2018-2025)
14.3 Global Metastatic Melanoma Drug Sales Volume, Revenue and Price Forecast by Type (2018-2025)
  14.3.1 Global Metastatic Melanoma Drug Sales Forecast by Type (2018-2025)
  14.3.2 Global Metastatic Melanoma Drug Revenue Forecast by Type (2018-2025)
  14.3.3 Global Metastatic Melanoma Drug Price Forecast by Type (2018-2025)
14.4 Global Metastatic Melanoma Drug Sales Volume Forecast by Application (2018-2025)

15 RESEARCH FINDINGS AND CONCLUSION

16 APPENDIX

16.1 Methodology/Research Approach
  16.1.1 Research Programs/Design
  16.1.2 Market Size Estimation
  16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
  16.2.1 Secondary Sources
  16.2.2 Primary Sources
16.3 Disclaimer

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Metastatic Melanoma Drug
Figure Global Metastatic Melanoma Drug Sales Volume Comparison (K Pcs) by Type (2013-2025)
Figure Global Metastatic Melanoma Drug Sales Volume Market Share by Type (Product Category) in 2017
Figure AGI-134 Product Picture
Figure ALT-801 Product Picture
Figure ALT-803 Product Picture
Figure AMG-232 Product Picture
Figure Others Product Picture
Figure Global Metastatic Melanoma Drug Sales Comparison (K Pcs) by Application (2013-2025)
Figure Global Sales Market Share of Metastatic Melanoma Drug by Application in 2017
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Clinic Examples
Table Key Downstream Customer in Clinic
Figure Others Examples
Table Key Downstream Customer in Others
Figure Global Metastatic Melanoma Drug Market Size (Million USD) by Regions (2013-2025)
Figure United States Metastatic Melanoma Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Europe Metastatic Melanoma Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure China Metastatic Melanoma Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Japan Metastatic Melanoma Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Southeast Asia Metastatic Melanoma Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure India Metastatic Melanoma Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Metastatic Melanoma Drug Sales Volume (K Pcs) and Growth Rate (2013-2025)
Figure Global Metastatic Melanoma Drug Revenue (Million USD) and Growth Rate (2013-2025)
Figure Global Market Major Players Metastatic Melanoma Drug Sales Volume (K Pcs) (2013-2018)
Table Global Metastatic Melanoma Drug Sales (K Pcs) of Key Players/Suppliers (2013-2018)
Table Global Metastatic Melanoma Drug Sales Share by Players/Suppliers (2013-2018)
Figure 2017 Metastatic Melanoma Drug Sales Share by Players/Suppliers
Figure 2017 Metastatic Melanoma Drug Sales Share by Players/Suppliers
Figure Global Metastatic Melanoma Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Metastatic Melanoma Drug Revenue (Million USD) by Players/Suppliers (2013-2018)
Table Global Metastatic Melanoma Drug Revenue Share by Players/Suppliers (2013-2018)
Table 2017 Global Metastatic Melanoma Drug Revenue Share by Players
Table 2017 Global Metastatic Melanoma Drug Revenue Share by Players
Table Global Metastatic Melanoma Drug Sales (K Pcs) and Market Share by Type (2013-2018)
Table Global Metastatic Melanoma Drug Sales Share (K Pcs) by Type (2013-2018)
Figure Sales Market Share of Metastatic Melanoma Drug by Type (2013-2018)
Figure Global Metastatic Melanoma Drug Sales Growth Rate by Type (2013-2018)
Table Global Metastatic Melanoma Drug Revenue (Million USD) and Market Share by Type (2013-2018)
Table Global Metastatic Melanoma Drug Revenue Share by Type (2013-2018)
Figure Revenue Market Share of Metastatic Melanoma Drug by Type (2013-2018)
Figure Global Metastatic Melanoma Drug Revenue Growth Rate by Type (2013-2018)
Table Global Metastatic Melanoma Drug Sales Volume (K Pcs) and Market Share by Region (2013-2018)
Table Global Metastatic Melanoma Drug Sales Share by Region (2013-2018)
Figure Sales Market Share of Metastatic Melanoma Drug by Region (2013-2018)
Figure Global Metastatic Melanoma Drug Sales Growth Rate by Region in 2017
Table Global Metastatic Melanoma Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Metastatic Melanoma Drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Metastatic Melanoma Drug by Region (2013-2018)
Figure Global Metastatic Melanoma Drug Revenue Growth Rate by Region in 2017
Table Global Metastatic Melanoma Drug Revenue (Million USD) and Market Share by Region (2013-2018)
Table Global Metastatic Melanoma Drug Revenue Share (%) by Region (2013-2018)
Figure Revenue Market Share of Metastatic Melanoma Drug by Region (2013-2018)
Figure Global Metastatic Melanoma Drug Revenue Market Share by Region in 2017
Table Global Metastatic Melanoma Drug Sales Volume (K Pcs) and Market Share by Application (2013-2018)
Table Global Metastatic Melanoma Drug Sales Share (%) by Application (2013-2018)
Figure Sales Market Share of Metastatic Melanoma Drug by Application (2013-2018)
Figure Global Metastatic Melanoma Drug Sales Market Share by Application (2013-2018)
Figure United States Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure United States Metastatic Melanoma Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure United States Metastatic Melanoma Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table United States Metastatic Melanoma Drug Sales Volume (K Pcs) by Players (2013-2018)
Table United States Metastatic Melanoma Drug Sales Volume Market Share by Players (2013-2018)
Figure United States Metastatic Melanoma Drug Sales Volume Market Share by Players in 2017
Table United States Metastatic Melanoma Drug Sales Volume (K Pcs) by Type (2013-2018)
Table United States Metastatic Melanoma Drug Sales Volume Market Share by Type (2013-2018)
Figure United States Metastatic Melanoma Drug Sales Volume Market Share by Type in 2017
Table United States Metastatic Melanoma Drug Sales Volume (K Pcs) by Application (2013-2018)
Table United States Metastatic Melanoma Drug Sales Volume Market Share by Application (2013-2018)
Figure United States Metastatic Melanoma Drug Sales Volume Market Share by Application in 2017
Figure Europe Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Europe Metastatic Melanoma Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Europe Metastatic Melanoma Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Europe Metastatic Melanoma Drug Sales Volume (K Pcs) by Players (2013-2018)
Table Europe Metastatic Melanoma Drug Sales Volume Market Share by Players (2013-2018)
Figure Europe Metastatic Melanoma Drug Sales Volume Market Share by Players in 2017
Table Europe Metastatic Melanoma Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Europe Metastatic Melanoma Drug Sales Volume Market Share by Type (2013-2018)
Figure Europe Metastatic Melanoma Drug Sales Volume Market Share by Type in 2017
Table Europe Metastatic Melanoma Drug Sales Volume (K Pcs) by Application (2013-2018)
Table Europe Metastatic Melanoma Drug Sales Volume Market Share by Application (2013-2018)
Figure Europe Metastatic Melanoma Drug Sales Volume Market Share by Application in 2017
Figure China Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure China Metastatic Melanoma Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure China Metastatic Melanoma Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table China Metastatic Melanoma Drug Sales Volume (K Pcs) by Players (2013-2018)
Table China Metastatic Melanoma Drug Sales Volume Market Share by Players (2013-2018)
Figure China Metastatic Melanoma Drug Sales Volume Market Share by Players in 2017
Table China Metastatic Melanoma Drug Sales Volume (K Pcs) by Type (2013-2018)
Table China Metastatic Melanoma Drug Sales Volume Market Share by Type (2013-2018)
Figure China Metastatic Melanoma Drug Sales Volume Market Share by Type in 2017
Table China Metastatic Melanoma Drug Sales Volume (K Pcs) by Application (2013-2018)
Table China Metastatic Melanoma Drug Sales Volume Market Share by Application (2013-2018)
Figure China Metastatic Melanoma Drug Sales Volume Market Share by Application in 2017
Figure Japan Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Japan Metastatic Melanoma Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Japan Metastatic Melanoma Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Japan Metastatic Melanoma Drug Sales Volume (K Pcs) by Players (2013-2018)
Table Japan Metastatic Melanoma Drug Sales Volume Market Share by Players (2013-2018)
Figure Japan Metastatic Melanoma Drug Sales Volume Market Share by Players in 2017
Table Japan Metastatic Melanoma Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Japan Metastatic Melanoma Drug Sales Volume Market Share by Type (2013-2018)
Figure Japan Metastatic Melanoma Drug Sales Volume Market Share by Type in 2017
Table Japan Metastatic Melanoma Drug Sales Volume (K Pcs) by Application (2013-2018)
Table Japan Metastatic Melanoma Drug Sales Volume Market Share by Application (2013-2018)
Figure Japan Metastatic Melanoma Drug Sales Volume Market Share by Application in 2017
Figure Southeast Asia Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure Southeast Asia Metastatic Melanoma Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure Southeast Asia Metastatic Melanoma Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table Southeast Asia Metastatic Melanoma Drug Sales Volume (K Pcs) by Players (2013-2018)
Table Southeast Asia Metastatic Melanoma Drug Sales Volume Market Share by Players (2013-2018)
Figure Southeast Asia Metastatic Melanoma Drug Sales Volume Market Share by Players in 2017
Table Southeast Asia Metastatic Melanoma Drug Sales Volume (K Pcs) by Type (2013-2018)
Table Southeast Asia Metastatic Melanoma Drug Sales Volume Market Share by Type (2013-2018)
Figure Southeast Asia Metastatic Melanoma Drug Sales Volume Market Share by Type in 2017
Table Southeast Asia Metastatic Melanoma Drug Sales Volume (K Pcs) by Application (2013-2018)
Table Southeast Asia Metastatic Melanoma Drug Sales Volume Market Share by Application (2013-2018)
Figure Southeast Asia Metastatic Melanoma Drug Sales Volume Market Share by Application in 2017
Figure India Metastatic Melanoma Drug Sales (K Pcs) and Growth Rate (2013-2018)
Figure India Metastatic Melanoma Drug Revenue (Million USD) and Growth Rate (2013-2018)
Figure India Metastatic Melanoma Drug Sales Price (USD/Pcs) Trend (2013-2018)
Table India Metastatic Melanoma Drug Sales Volume (K Pcs) by Players (2013-2018)
Table India Metastatic Melanoma Drug Sales Volume Market Share by Players (2013-2018)
Figure India Metastatic Melanoma Drug Sales Volume Market Share by Players in 2017
Table India Metastatic Melanoma Drug Sales Volume (K Pcs) by Type (2013-2018)
Table India Metastatic Melanoma Drug Sales Volume Market Share by Type (2013-2018)
Figure India Metastatic Melanoma Drug Sales Volume Market Share by Type in 2017
Table India Metastatic Melanoma Drug Sales Volume (K Pcs) by Application (2013-2018)
Table India Metastatic Melanoma Drug Sales Volume Market Share by Application (2013-2018)
Figure India Metastatic Melanoma Drug Sales Volume Market Share by Application in 2017
Table Merck & Co., Inc. Basic Information List
Table Merck & Co., Inc. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Merck & Co., Inc. Metastatic Melanoma Drug Sales Growth Rate (2013-2018)
Figure Merck & Co., Inc. Metastatic Melanoma Drug Sales Global Market Share (2013-2018)
Figure Merck & Co., Inc. Metastatic Melanoma Drug Revenue Global Market Share (2013-2018)
Table Merck KGaA Basic Information List
Table Merck KGaA Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Merck KGaA Metastatic Melanoma Drug Sales Growth Rate (2013-2018)
Figure Merck KGaA Metastatic Melanoma Drug Sales Global Market Share (2013-2018)
Figure Merck KGaA Metastatic Melanoma Drug Revenue Global Market Share (2013-2018)
Table Millennium Pharmaceuticals, Inc. Basic Information List
Table Millennium Pharmaceuticals, Inc. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Millennium Pharmaceuticals, Inc. Metastatic Melanoma Drug Sales Growth Rate (2013-2018)
Figure Millennium Pharmaceuticals, Inc. Metastatic Melanoma Drug Sales Global Market Share (2013-2018
Figure Millennium Pharmaceuticals, Inc. Metastatic Melanoma Drug Revenue Global Market Share (2013-2018)
Table Morphotek, Inc. Basic Information List
Table Morphotek, Inc. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Morphotek, Inc. Metastatic Melanoma Drug Sales Growth Rate (2013-2018)
Figure Morphotek, Inc. Metastatic Melanoma Drug Sales Global Market Share (2013-2018)
Figure Morphotek, Inc. Metastatic Melanoma Drug Revenue Global Market Share (2013-2018)
Table NewLink Genetics Corporation Basic Information List
Table NewLink Genetics Corporation Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure NewLink Genetics Corporation Metastatic Melanoma Drug Sales Growth Rate (2013-2018)
Figure NewLink Genetics Corporation Metastatic Melanoma Drug Sales Global Market Share (2013-2018)
Figure NewLink Genetics Corporation Metastatic Melanoma Drug Revenue Global Market Share (2013-2018)
Table Novartis AG Basic Information List
Table Novartis AG Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Novartis AG Metastatic Melanoma Drug Sales Growth Rate (2013-2018)
Figure Novartis AG Metastatic Melanoma Drug Sales Global Market Share (2013-2018
Figure Novartis AG Metastatic Melanoma Drug Revenue Global Market Share (2013-2018)
Table Omeros Corporation Basic Information List
Table Omeros Corporation Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Omeros Corporation Metastatic Melanoma Drug Sales Growth Rate (2013-2018)
Figure Omeros Corporation Metastatic Melanoma Drug Sales Global Market Share (2013-2018)
Figure Omeros Corporation Metastatic Melanoma Drug Revenue Global Market Share (2013-2018)
Table Oncolytics Biotech Inc. Basic Information List
Table Oncolytics Biotech Inc. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Oncolytics Biotech Inc. Metastatic Melanoma Drug Sales Growth Rate (2013-2018)
Figure Oncolytics Biotech Inc. Metastatic Melanoma Drug Sales Global Market Share (2013-2018
Figure Oncolytics Biotech Inc. Metastatic Melanoma Drug Revenue Global Market Share (2013-2018)
Table OncoSec Medical Inc. Basic Information List
Table OncoSec Medical Inc. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure OncoSec Medical Inc. Metastatic Melanoma Drug Sales Growth Rate (2013-2018)
Figure OncoSec Medical Inc. Metastatic Melanoma Drug Sales Global Market Share (2013-2018)
Figure OncoSec Medical Inc. Metastatic Melanoma Drug Revenue Global Market Share (2013-2018)
Table Ono Pharmaceutical Co., Ltd. Basic Information List
Table Ono Pharmaceutical Co., Ltd. Metastatic Melanoma Drug Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)
Figure Ono Pharmaceutical Co., Ltd. Metastatic Melanoma Drug Sales Growth Rate (2013-2018)
Figure Ono Pharmaceutical Co., Ltd. Metastatic Melanoma Drug Sales Global Market Share (2013-2018)
Figure Ono Pharmaceutical Co., Ltd. Metastatic Melanoma Drug Revenue Global Market Share (2013-2018)
Table Pfizer Inc. Basic Information List
Table Pharmis Biofarmaceutica, Lda. Basic Information List
Table Philogen S.p.A. Basic Information List
Table Plexxikon Inc. Basic Information List
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Metastatic Melanoma Drug
Figure Manufacturing Process Analysis of Metastatic Melanoma Drug
Figure Metastatic Melanoma Drug Industrial Chain Analysis
Table Raw Materials Sources of Metastatic Melanoma Drug Major Players in 2017
Table Major Buyers of Metastatic Melanoma Drug
Table Distributors/Traders List
Figure Global Metastatic Melanoma Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Global Metastatic Melanoma Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Global Metastatic Melanoma Drug Price (USD/Pcs) and Trend Forecast (2018-2025)
Table Global Metastatic Melanoma Drug Sales Volume (K Pcs) Forecast by Regions (2018-2025)
Figure Global Metastatic Melanoma Drug Sales Volume Market Share Forecast by Regions (2018-2025)
Figure Global Metastatic Melanoma Drug Sales Volume Market Share Forecast by Regions in 2025
Table Global Metastatic Melanoma Drug Revenue (Million USD) Forecast by Regions (2018-2025)
Figure Global Metastatic Melanoma Drug Revenue Market Share Forecast by Regions (2018-2025)
Figure Global Metastatic Melanoma Drug Revenue Market Share Forecast by Regions in 2025
Figure United States Metastatic Melanoma Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure United States Metastatic Melanoma Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Europe Metastatic Melanoma Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Europe Metastatic Melanoma Drug Revenue and Growth Rate Forecast (2018-2025)
Figure China Metastatic Melanoma Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure China Metastatic Melanoma Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Japan Metastatic Melanoma Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Japan Metastatic Melanoma Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Metastatic Melanoma Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure Southeast Asia Metastatic Melanoma Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Figure India Metastatic Melanoma Drug Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)
Figure India Metastatic Melanoma Drug Revenue (Million USD) and Growth Rate Forecast (2018-2025)
Table Global Metastatic Melanoma Drug Sales (K Pcs) Forecast by Type (2018-2025)
Figure Global Metastatic Melanoma Drug Sales Volume Market Share Forecast by Type (2018-2025)
Table Global Metastatic Melanoma Drug Revenue (Million USD) Forecast by Type (2018-2025)
Figure Global Metastatic Melanoma Drug Revenue Market Share Forecast by Type (2018-2025)
Table Global Metastatic Melanoma Drug Price (USD/Pcs) Forecast by Type (2018-2025)
Table Global Metastatic Melanoma Drug Sales (K Pcs) Forecast by Application (2018-2025)
Figure Global Metastatic Melanoma Drug Sales Market Share Forecast by Application (2018-2025)
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources